Refractory Hypercalcemia in Squamous Cell Carcinoma of the Esophagus-a Case Report and Review of Literature

J Gastrointest Cancer. 2019 Dec;50(4):939-942. doi: 10.1007/s12029-018-0124-1.

Authors

Hamza Arif¹, Moeezullah Beg², Sohaib Zahid², Moaz Sial³, Aditya Talwar⁴, Antonios Christou⁵, Michael Babich³

Affiliations

¹ Department of Internal Medicine, Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA, 15212, USA. hamza.arif@ahn.org.
² Department of Internal Medicine, Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA, 15212, USA.
³ Department of Gastroenterology, Hepatology and Nutrition, Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA, 15212, USA.
⁴ Department of Pathology, Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA, 15212, USA.
⁵ Department of Hematology & Oncology, Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA, 15212, USA.

PMID: 29862439
DOI: 10.1007/s12029-018-0124-1

No abstract available

Publication types

Case Reports
Review

MeSH terms

Calcitonin / pharmacology
Calcitonin / therapeutic use
Calcium / blood*
Calcium-Regulating Hormones and Agents / pharmacology*
Calcium-Regulating Hormones and Agents / therapeutic use
Carcinoma, Squamous Cell / blood
Carcinoma, Squamous Cell / complications*
Carcinoma, Squamous Cell / pathology
Carcinoma, Squamous Cell / therapy
Cinacalcet / pharmacology
Cinacalcet / therapeutic use
Drug Resistance
Endoscopy, Digestive System
Esophageal Neoplasms / blood
Esophageal Neoplasms / complications*
Esophageal Neoplasms / pathology
Esophageal Neoplasms / therapy
Esophagus / diagnostic imaging
Esophagus / pathology
Fatal Outcome
Humans
Hypercalcemia / blood
Hypercalcemia / diagnosis
Hypercalcemia / drug therapy*
Male
Middle Aged
Pamidronate / pharmacology
Pamidronate / therapeutic use
Positron-Emission Tomography

Substances

Calcium-Regulating Hormones and Agents
Calcitonin
Pamidronate
Calcium
Cinacalcet